IRCT20221108056440N1
Recruiting
Phase 3
Comparison of the Effectiveness of l_arginine plus aspirin with aspirin alone in preventing adverse outcomes in pregnant women at high risk of preeclampsia
Overview
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 90
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- Female
Inclusion Criteria
- •Pregnant women who are at high risk for preeclampsia
- •Pregnant women with a gestational age between 14 and 28 weeks of pregnancy
- •Previous history of pre\-eclampsia in the individual or first degree relatives of the individual's sister or mother
- •Women with a history of chronic hypertension
- •Body mass index greater than 30
- •Multiple pregnancy
- •Lipid disorders
Exclusion Criteria
- •Drug sensitivity to L\-arginine
- •Drug sensitivity to aspirin
Investigators
Similar Trials
Completed
Phase 3
Investigating the effectiveness of L-arginine in reducing duration of hospitalization and pain intensity of children with sickle cell disease compared to placebo.Sickle cell disease.Other sickle-cell disorders with crisisD57.81IRCT20170112031891N2Ahvaz University of Medical Sciences120
Not yet recruiting
Not Applicable
recording efficacy of l-arginine in improving outcomes in patients with oligohydramniosHealth Condition 1: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperiumCTRI/2024/04/065276none
Recruiting
Phase 3
Effect of L-arginine versus control group on the prevention of preeclampsia in primiparous pregnant womeIRCT20120215009014N416Hamedan University of Medical Sciences172
Completed
Not Applicable
The effect of L- arginine supplementation on metabolic syndrome.Metabolic Syndrome.-IRCT2015120425245N2for research of Yazd Shahid Sadoughi University of Medical Sciences60
Not yet recruiting
Not Applicable
Effects of Arginine Supplementation associated with an Exercise Training Program in Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease, Unspecified / Chronic Obstructive Pulmonary DiseaseRBR-8rkwnwniversidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA